# Investigation of ADA Enzyme Deficiency

> **NCT05300334** · — · UNKNOWN · sponsor: **TRPHARM** · enrollment: 800 (estimated)

## Conditions studied

- Adenosine Deaminase Deficiency

## Interventions

- **DIAGNOSTIC_TEST:** adenosine deaminase test

## Key facts

- **NCT ID:** NCT05300334
- **Lead sponsor:** TRPHARM
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-10
- **Primary completion:** 2020-11-05
- **Final completion:** 2022-10-10
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2022-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05300334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05300334, "Investigation of ADA Enzyme Deficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05300334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*